Brazilian state of Bahia to test Russia's vaccine, plans to buy 50 million doses

The Russian vaccine is being developed by Moscow`s Gamaleya Research Institute and marketed by the Russian Direct Investment Fund (RDIF), which last month also entered an agreement with the Brazilian state of Paraná to test and produce the vaccine.